The global market is estimated to value at US$7.0 Bn by the end of 2031 from US$2.1 Bn estimated to be recorded in 2024. The market is expected to secure a CAGR of 18.4% in the forthcoming years from 2024 to 2031.
Rising demand for gene therapies, and rapidly expanding gene therapy applications will drive market growth.
The incorporation of automation, and AI in plasmid DNA manufacturing processes is a key market trend revolutionizing the DNA manufacturing landscape.
Innovations in purification methods, such as chromatography and filtration technologies, have significantly improved the purity and yield of plasmid DNA.